期刊文献+

Fractalkine在大鼠肝硬化中全肝血流阻断致肺损伤中表达 被引量:1

Expression of Fractalkine in lung injury induced by total hepatic blood flow occlusion in rat liver cirrhosis model
下载PDF
导出
摘要 目的探讨趋化因子Fractalkine(Fkn,CX3CL1)在大鼠肝硬化模型中全肝血流阻断致肺损伤中表达及意义。方法选择80只雄性成年SD大鼠,鼠龄2.0~2.5个月,体质量160~200 g。随机分为4组(n=20),即对照组(A组),阻断肝门、肝上下腔静脉及肝下下腔静脉15 min(B组)、30min(C组)、45 min(D组);制作肝硬化大鼠全肝血流阻断模型。取右肺下叶肺组织常规苏木精-伊红(HE)染色病理检查,留取肺及肝组织检测Fkn的表达,并切取肺组织及血浆检测核因子-κB(NF-κB)及白细胞介素21(IL-21)水平变化。结果各组成功建模后,D组肺损伤病理评分[(12.25±1.52)分]明显高于A组[(2.05±1.00)分]、B组[(7.90±1.62)分]及C组[(8.25±1.55)分](P<0.001),A组无明显病理改变。在各组肝、肺组织中Fkn的表达测定中,D组Fkn表达明显高于B组、C组及A组(P<0.05)。血清中NF-κB、IL-21表达在A组[(11.67±2.11) ng/L,(633.30±42.03) ng/L]最低(P<0.05),D组[(18.13±1.83) ng/L,(801.96±54.38) ng/L]明显高于B组[(14.72±2.56) ng/L,(712.67±53.63) ng/L]及C组[(15.23±2.26) ng/L,(713.59±61.60) ng/L](P<0.05)。肺组织中NF-κB、IL-21表达A组[(14.48±2.07) ng/L,(590.89±55.38) ng/L]最低(P<0.05),D组[(19.66±1.53) ng/L,(910.85±87.63) ng/L]明显高于B组[(16.65±1.75) ng/L,(696.23±51.91) ng/L]及C组[(17.02±1.47) ng/L,(697.22±41.24)ng/L](P<0.05)。结论 Fkn在肝硬化大鼠全肝血流阻断致肺组织损伤时表达增加,且阻断时间超过30 min后更加明显。 Objective To investigate the expression and significance of Fractalkine(Fkn) in lung injury induced by total hepatic blood flow occlusion in rat liver cirrhosis model. Methods Eighty adult male SD rats aged 2.0-2.5 months old with body weight of 160-200 g were randomly divided into 4 groups(n = 20): control group(group A, hilar, supra-supercavity, and inferior liver were blocked), group B(the hepatic cirrhosis rats were subjected to hepatic hepatic occlusion for 15-minute), group C(30-minute) and group D(45-minute). The pathological examination of right lower lobe lung tissue was performed by hematoxylineosin(HE) staining, lung and liver tissues were collected for detection of Fkn expression, and lung tissue and plasma were harvested for detection of nuclear factor kappa-B(NF-KB) and interleukin-21(IL-21) levels. Results After successful modeling,the pathological scores of lung injury in group D[(12.25± 1.52) scores] were significantly higher than those in group A[(2.05 ±1.00) scores], group B[(7.90 ± 1.62) scores] and group C[(8.25 ± 1.55) scores](P < 0.001), while there was no significant pathological changes in group A. The expression of Fkn in group D was significantly higher than that in group B, group C and group A(P< 0.05). The expression of serum NF-κB and IL-21 was the lowest in group A(11.67 ng/L ± 2.11 ng/L, 633.30 ng/L ±42.03 ng/L)(P< 0.05),and expression of NF-κB and IL-21 in group D(18.13 ng/L ± 1.83 ng/L, 801.96 ng/L ± 54.38 ng/L) was higher than that in group B(14.72 ng/L ± 2.56 ng/L, 712.67 ng/L ± 53.63 ng/L) and group C(15.23 ng/L ± 2.26 ng/L, 713.59 ng/L ±61.60 ng/L)(P< 0.05). The expression of NF-κB and IL-21 in lung tissue was the lowest in group A( 14.48 ng/L ± 2.07 ng/L590.89 ng/L ± 55.38 ng/L)(P< 0.05),and expression of NF-κB and IL-21 in group D(19.66 ng/L ± 1.53 ng/L, 910.85 ng/L ±87.63 ng/L) was significantly higher than that in group B(16.65 ng/L ± 1.75 ng/L,696.23 ng/L ± 51.91 ng/L) and group C(17.02 ng/L ± 1.47 ng/L, 697.22 ng/L ± 41.24 ng/L)(P < 0.05). Conclusion It is demonstrated that the expression of Fkn is increased in lung tissue injury induced by total hepatic blood flow occlusion in cirrhotic rats, and it is more obvious after the blockage time exceeds 30-minute.
作者 王翀 盛冠男 徐敏 杨涛 孟珂伟 WANG Chong;SHENG Guan-nan;XU Min;YANG Tao;MENG Ke-wei(Department of General Surgery, Tianjin First Central Hospital, Tianjin 300192, China;Tianjin Medical University Frist Central Clinical College, Tianjin 300192, China)
出处 《生物医学工程与临床》 CAS 2019年第3期331-336,共6页 Biomedical Engineering and Clinical Medicine
关键词 肝硬化 肺损伤 Fractalkine(Fkn) 核因子-κB(NF-κB) 白细胞介素21(IL-21) liver cirrhosis lung injury Fractalkine(Fkn) nuclear factor kappa-B(NF-κB) interleukin-21(IL-21)
  • 相关文献

参考文献1

二级参考文献12

  • 1Hui-Xing Chen, Guang-Wen Zhou,Lu Yin,Cheng-Hong Peng and Hong-Wei Li Shanghai, China Department of Surgery and Center of Organ Transplantation, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025,China.Liver regeneration after split liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2005,4(4):519-523. 被引量:2
  • 2Yock-Young Dan,Chun-Tao Wai,Yin-Mei Lee,Dede Selamat Sutedja,Bee-Leng Seer,Seng-Gee Lim.Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics[J].World Journal of Gastroenterology,2005,11(28):4344-4350. 被引量:1
  • 3D.J.W. Wesdorp,M. Knoester,A.E. Braat,M.J. Coenraad,A.C.T.M. Vossen,E.C.J. Claas,B. van Hoek.Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective[J]. Journal of Clinical Virology . 2013
  • 4E. Cholongitas,G.V. Papatheodoridis.High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review[J]. American Journal of Transplantation . 2012 (2)
  • 5Anis Khan,Mohammed A. Al Balwi,Yasuhito Tanaka,Ali Hajeer,Faisal M. Sanai,Ibrahim Al Abdulkarim,Latifah Al Ayyar,Motasim Badri,Dib Saudi,Waleed Tamimi,Masashi Mizokami,Bandar Al Knawy.Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia[J].Int J Cancer.2013(12)
  • 6Mustafa Sunbul,Masaya Sugiyama,Fuat Kurbanov,Hakan Leblebicioglu,Anis Khan,Abeer Elkady,Yasuhito Tanaka,Masashi Mizokami.Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey[J].Microbiol Immunol.2013(2)
  • 7Anna S. Lok,Huy Trinh,Giampiero Carosi,Ulus S. Akarca,Adrian Gadano,Fran?ois Habersetzer,William Sievert,David Wong,Meghan Lovegren,David Cohen,Cyril Llamoso.Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Na?ve Patients With Chronic Hepatitis B[J].Gastroenterology.2012(3)
  • 8Ting-Jung Wu,Kun-Ming Chan,Hong-Shiue Chou,Chen-Fang Lee,Tsung-Han Wu,Tse-Ching Chen,Chau-Ting Yeh,Wei-Chen Lee.Liver Transplantation in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: The Influence of Viral Characteristics on Clinical Outcome[J].Annals of Surgical Oncology.2013(11)
  • 9Matthew S. Chang,Sonja K. Olsen,Elsa M. Pichardo,Jessica B. Stiles,Lori Rosenthal-Cogan,William D. Brubaker,James V. Guarrera,Jean C. Emond,Robert S. Brown.Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience[J].Transplantation Journal.2013(7)
  • 10Fabien Zoulim,Stephen Locarnini.Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance[J].Liver Int.2013

共引文献6

同被引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部